Solid Biosciences Inc.

SLDB | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.88

+$0.34 (+3.98%)

Sep 22, 2026, 1:58 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $840.76M

Enterprise Value $483.24M

Beta 2.44

Average Volume 1.45M

Shares Outstanding (Diluted) 143.69M

Shares Change YoY 52.63%

Institutional Ownership 90.79%

Exchange NASDAQ

ISIN US83422E2046

Price Performance

Price Change 1M -7.7%

Price Change 3M -2.8%

Price Change 6M 18.1%

Price Change YTD 56.7%

Price Change 1Y 65.2%

Price Change 3Y 209.4%

Price Change 5Y -78.7%

1M CAGR (ann.) 1.8%

1Y CAGR (ann.) 57.0%

5Y CAGR (ann.) -26.6%

All-Time CAGR -34.6%

Valuation

PE Ratio -4.47

Forward PE N/A

PEG Ratio -0.14

Forward PEG 2.76

PS Ratio N/A

Forward PS 70.30

PB Ratio 2.25

P/FCF Ratio -3.57

P/Adj. FCF Ratio -3.21

P/OCF Ratio -6.57

EV/Sales N/A

EV/EBIT -2.33

EV/EBITDA -2.36

EV/FCF -2.05

Earnings Yield -22.4%

FCF Yield -28.0%

Adj. FCF Yield -31.1%

Financial Health

Net Cash $357.52M

Total Debt $20.16M

Cash & Short-Term Investments $377.68M

Total Assets $420.58M

Current Ratio 13.82

Quick Ratio 13.82

Debt / Equity Ratio 0.05

Debt / EBITDA -0.10

Debt / FCF -0.09

OCF / Debt -11.61

Interest Coverage 0.00

Altman Z-Score 6.71

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -11.2%

Returns

Return on Assets -49.2%

Return on Equity -72.3%

Return on Invested Capital -53.8%

Return on Capital Employed -54.1%

Return on Tangible Assets -49.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y 10.6%

EPS CAGR 3Y 21.8%

EPS CAGR 5Y 45.5%

EPS CAGR 10Y 18.9%

FCF CAGR 3Y -50.2%

FCF CAGR 5Y -24.2%

FCF CAGR 10Y -12.7%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 23

EPS Growth Next 3Y 30.4%

Revenue Growth Next 3Y N/A

Earnings Date Nov 1, 2026

EPS Estimate (next Q) -$0.37

EPS Growth Est (next Q) -22.9%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $20.50

Price Target Upside 140.0%

Cash Flow

Operating Cash Flow $-234.07M

Free Cash Flow $-235.2M

Adj. Free Cash Flow $-261.55M

FCF Per Share -$1.31

OCF Per Share -$1.30

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-395K

Operating Income $-212.15M

EBITDA $-205.08M

Net Income $-207.1M

EPS (Diluted) -$1.91

Revenue / Employee N/A

Profit / Employee $-1.71M

Employees 121